MPL Stock Overview
Medibank Private Limited provides private health insurance and health services in Australia.
Medibank Private Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$3.47|
|52 Week High||AU$3.79|
|52 Week Low||AU$3.00|
|1 Month Change||-5.71%|
|3 Month Change||7.43%|
|1 Year Change||-1.70%|
|3 Year Change||6.77%|
|5 Year Change||16.84%|
|Change since IPO||62.15%|
Recent News & Updates
Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073
Medibank Private Limited ( ASX:MPL ) has announced that it will be increasing its periodic dividend on the 29th of...
|MPL||AU Insurance||AU Market|
Return vs Industry: MPL exceeded the Australian Insurance industry which returned -5.6% over the past year.
Return vs Market: MPL exceeded the Australian Market which returned -10.8% over the past year.
|MPL Average Weekly Movement||2.6%|
|Insurance Industry Average Movement||3.8%|
|Market Average Movement||9.4%|
|10% most volatile stocks in AU Market||16.5%|
|10% least volatile stocks in AU Market||4.2%|
Stable Share Price: MPL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: MPL's weekly volatility (3%) has been stable over the past year.
About the Company
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy.
Medibank Private Fundamentals Summary
|MPL fundamental statistics|
Is MPL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MPL income statement (TTM)|
|Cost of Revenue||AU$5.68b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.14|
|Net Profit Margin||5.54%|
How did MPL perform over the long term?See historical performance and comparison
3.9%Current Dividend Yield
Is MPL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MPL?
Other financial metrics that can be useful for relative valuation.
|What is MPL's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does MPL's PE Ratio compare to its peers?
|MPL PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
NHF nib holdings
GDG Generation Development Group
IAG Insurance Australia Group
SUN Suncorp Group
MPL Medibank Private
Price-To-Earnings vs Peers: MPL is good value based on its Price-To-Earnings Ratio (24.3x) compared to the peer average (50.1x).
Price to Earnings Ratio vs Industry
How does MPL's PE Ratio compare vs other companies in the Global Insurance Industry?
Price-To-Earnings vs Industry: MPL is expensive based on its Price-To-Earnings Ratio (24.3x) compared to the Global Insurance industry average (11.2x)
Price to Earnings Ratio vs Fair Ratio
What is MPL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||24.3x|
|Fair PE Ratio||26.8x|
Price-To-Earnings vs Fair Ratio: MPL is good value based on its Price-To-Earnings Ratio (24.3x) compared to the estimated Fair Price-To-Earnings Ratio (26.8x).
Share Price vs Fair Value
What is the Fair Price of MPL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MPL (A$3.47) is trading below our estimate of fair value (A$5.28)
Significantly Below Fair Value: MPL is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Medibank Private forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MPL's forecast earnings growth (7.3% per year) is above the savings rate (1.8%).
Earnings vs Market: MPL's earnings (7.3% per year) are forecast to grow faster than the Australian market (6.5% per year).
High Growth Earnings: MPL's earnings are forecast to grow, but not significantly.
Revenue vs Market: MPL's revenue (4.7% per year) is forecast to grow faster than the Australian market (3.7% per year).
High Growth Revenue: MPL's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MPL's Return on Equity is forecast to be high in 3 years time (24.4%)
Discover growth companies
How has Medibank Private performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MPL has high quality earnings.
Growing Profit Margin: MPL's current net profit margins (5.5%) are lower than last year (6.3%).
Past Earnings Growth Analysis
Earnings Trend: MPL's earnings have declined by 2.2% per year over the past 5 years.
Accelerating Growth: MPL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MPL had negative earnings growth (-10.7%) over the past year, making it difficult to compare to the Insurance industry average (-20.4%).
Return on Equity
High ROE: MPL's Return on Equity (20.2%) is considered high.
Discover strong past performing companies
How is Medibank Private's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: MPL's short term assets (A$3.7B) exceed its short term liabilities (A$2.4B).
Long Term Liabilities: MPL's short term assets (A$3.7B) exceed its long term liabilities (A$167.2M).
Debt to Equity History and Analysis
Debt Level: MPL is debt free.
Reducing Debt: MPL has not had any debt for past 5 years.
Debt Coverage: MPL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MPL has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Medibank Private current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Medibank Private Dividend Yield vs Market|
|Company (Medibank Private)||3.9%|
|Market Bottom 25% (AU)||2.8%|
|Market Top 25% (AU)||7.2%|
|Industry Average (Insurance)||3.0%|
|Analyst forecast in 3 Years (Medibank Private)||4.6%|
Notable Dividend: MPL's dividend (3.86%) is higher than the bottom 25% of dividend payers in the Australian market (2.8%).
High Dividend: MPL's dividend (3.86%) is low compared to the top 25% of dividend payers in the Australian market (7.16%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, MPL has been paying a dividend for less than 10 years.
Growing Dividend: MPL's dividend payments have increased, but the company has only paid a dividend for 7 years.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (93.7%), MPL's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (40.4%), MPL's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Koczkar (49 yo)
Mr. David Koczkar, BCom, PG Dip Finance, MAICD, serves as Managing Director, Director and Chief Executive Officer at Medibank Private Limited since May 17, 2021 and served as Group Executive and Chief Cust...
CEO Compensation Analysis
|David Koczkar's Compensation vs Medibank Private Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||AU$4m||AU$2m|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||n/a||n/a|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||AU$2m||AU$1m|
|Mar 31 2021||n/a||n/a|
|Dec 31 2020||n/a||n/a|
|Sep 30 2020||n/a||n/a|
|Jun 30 2020||AU$1m||AU$919k|
|Mar 31 2020||n/a||n/a|
|Dec 31 2019||n/a||n/a|
|Sep 30 2019||n/a||n/a|
|Jun 30 2019||AU$2m||AU$866k|
|Dec 31 2018||n/a||n/a|
|Sep 30 2018||n/a||n/a|
|Jun 30 2018||AU$2m||AU$802k|
|Mar 31 2018||n/a||n/a|
|Dec 31 2017||n/a||n/a|
|Sep 30 2017||n/a||n/a|
|Jun 30 2017||AU$2m||AU$802k|
|Mar 31 2017||n/a||n/a|
|Dec 31 2016||n/a||n/a|
|Sep 30 2016||n/a||n/a|
|Jun 30 2016||AU$2m||AU$789k|
Compensation vs Market: David's total compensation ($USD2.42M) is about average for companies of similar size in the Australian market ($USD2.94M).
Compensation vs Earnings: David's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Experienced Management: MPL's management team is seasoned and experienced (5.7 years average tenure).
Experienced Board: MPL's board of directors are considered experienced (5.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
|26 Apr 22||BuyAU$23,230,111||The Vanguard Group, Inc.||Company||6,452,808||AU$3.60|
|19 Apr 22||SellAU$12,834,785||The Vanguard Group, Inc.||Company||3,795,552||AU$3.50|
|22 Mar 22||BuyAU$150,524||Gerard Dalbosco||Individual||48,400||AU$3.11|
|04 Nov 21||BuyAU$18,124,732||State Street Global Advisors, Inc.||Company||5,083,614||AU$3.59|
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Medibank Private Limited's employee growth, exchange listings and data sources
- Name: Medibank Private Limited
- Ticker: MPL
- Exchange: ASX
- Founded: 1976
- Industry: Life and Health Insurance
- Sector: Insurance
- Implied Market Cap: AU$9.564b
- Shares outstanding: 2.76b
- Website: https://www.medibank.com.au
Number of Employees
- Medibank Private Limited
- 720 Bourke Street
- Level 6
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MPL||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Nov 2014|
|MPL||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Nov 2014|
|MPV||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Nov 2014|
|MDBP.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Nov 2014|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/01 00:00|
|End of Day Share Price||2022/09/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.